Secondary analysis of two phase III lampalizumab trials in 856 participants with bilateral geographic atrophy: only minimum GA extent within the central 2.50-mm region (P < 0.001), not the 2.50-6.00-mm annulus, was independently associated with vision-related quality of life.
Secondary analysisn = 856
Anegondi et al. Vision-Related Quality of Life in Geographic Atrophy: Association with Topographic Lesion Distribution